Skip to main content
Premium Trial:

Request an Annual Quote

Walter Plosila, Marie Csete, Jeanine Burmania, Deven McGlenn, Frederic Pla, Eric Stahre, Colin Scanes, Karen Dettinger, Krystal Sanchez, Charles Morton Jr., Cathy Minehan, Gloria Larson, Lisa Lynch, Jack Meyer, Henri Termeer, Stuart Reese, James Stock, Jo


Battelle’s Walter Plosila Retires; Shaped Growth of Life Sciences Clusters in 45 Regions

Walter Plosila has retired from the Cleveland-based Battelle Institute, where he served as vice president of its technology partnership practice, capping a 25-year career in which he played a key role in the development of life sciences clusters in dozens of states and regions nationwide.
Plosila’s retirement took effect March 1. He will continue his association with Battelle by working as a part-time consultant to the global R&D and laboratory management organization, which is headquartered in Columbus, Ohio.
Over the past 25 years, the last 10 with Battelle, Plosila has served as a consultant to some 45 states and regions in economic development, entrepreneurship, technology, and business-higher education relationships. Plosila served as principal author for the technology partnership practice’s original 2002 “roadmap” report guiding the development of the life sciences cluster in Arizona, plus numerous follow-up reports, the most recent one completed late last year [BioRegion News, Feb. 25].
Plosila and the practice have also studied life sciences development trends in such regions as Colorado, Georgia, Indianapolis, Iowa, Memphis, Oklahoma City, Pittsburgh, St. Louis, and Washington State; as well as Indianapolis, Memphis, Oklahoma City, Pittsburgh, and the St. Louis region’s “BioBelt.”
Before joining Battelle in 1998, Plosila served as executive director of the North Carolina Alliance for Competitive Technologies, and earlier served eight years as president of the non-profit Suburban Maryland Technology Council, now known as the Technology Council of Maryland. There, he helped fuse Maryland’s concentration of federal agencies, biotech businesses and research institutes into a top-five life sciences cluster.
For over 11 years, while deputy secretary of Pennsylvania’s Department of Commerce and director of the Pennsylvania Governor's Office of Policy and Planning, Plosila developed one of the country's most comprehensive technology efforts — including establishment of the Ben Franklin Technology Partnership programs, which provide entrepreneurial support and financial assistance to technology firms and early stage companies.
Plosila has a PhD from the University of Pittsburgh, from which he also received a Distinguished Service Award; an MA from Pennsylvania State University; and a BA from Beloit (Wisc.) College.

Emory University Professor Heads West, Joining CIRM as Chief Scientific Officer
Marie Csete has joined the California Institute for Regenerative Medicine as chief scientific officer. The position marks an expansion of her role with California’s stem cell research funding agency; since 2005, Csete had been a member of the CIRM Scientific and Medical Research Funding Working Group.
Before joining CIRM full-time, Csete was previously John E. Steinhaus professor of anesthesiology at Emory University, with an adjunct appointment in cell biology, and program faculty appointments in biochemistry, cell and developmental biology, neurosciences, and the joint biomedical engineering program of Emory and Georgia Tech. She also served as director of Liver Transplant Anesthesiology at the Emory University Hospital in Atlanta, director of the Emory/Georgia Tech Human Embryonic Stem Cell Core, and co-director of Emory’s MD/PhD program.
Csete graduated from Princeton University with a degree in music, and received a PhD from California Institute of Technology, where her work focused on the role of physiologic gases in stem cell fate. She received her MD degree from Columbia University’s College of Physicians & Surgeons. After residency and fellowship training at the Massachusetts General Hospital and St. Elizabeth’s Hospital in Boston, she was assistant professor in residence at the University of California, San Francisco, where she directed the liver transplant anesthesiology team.

Wisconsin Biotechnology and Medical Device Association Names Five Board Members, Two Staffers
Five new members have been elected to the board of directors of the Wisconsin Biotechnology and Medical Device Association. Each will serve a three-year term that began on Jan. 1:
  • Jeanine Burmania, licensing associate at the Wisconsin Alumni Research Foundation in Madison;
  • Deven McGlenn, CEO of NeoClone, a Madison-based producer of monoclonal antibodies used in drug discovery and diagnostics; 
  • Frederic Pla, vice president and general manager of Invitrogen's transplant diagnostics business unit, based in Milwaukee;
  • Eric Stahre, general manager of Premium Computed Tomography, a $1 billion global segment within Waukesha-based GE Healthcare’s Diagnostic Imaging business; and
  • Colin Scanes, vice chancellor for research and economic development, and dean of the graduate school at the University of Wisconsin-Milwaukee.
WBMA also announced the appointment of two new staff members to positions intended to complete the group’s transition to a free-standing, independent organization:
  • Karen Dettinger has been named the association’s operations director. Prior to joining the WBMA, she worked as an independent consultant and was a partner and managing director at Affiliated Engineers in Madison. 
  • Krystal Sanchez has been appointed administrative assistant. Sanchez held a number of marketing support functions at Thermo Fisher Scientific and also served as assistant to the director of advancement at Edgewood College. She earned a bachelor’s degree in marketing at Edgewood College.

Maryland Technology Development Corporation Taps Lawyer for Full Board Term

Charles Morton Jr., a partner with the law firm Venable LLP and member of the firm’s business transactions practice group, has been appointed to a full term with the board of directors of the Maryland Technology Development Corporation, also known as TEDCO.

Morton, who is based in Venable’s Baltimore office, had been an acting member of TEDCO’s board since September 2007, following his appointment by Maryland Gov. Martin O’Malley. He is the only lawyer on TEDCO’s current 15-member board.

Morton has represented entrepreneurs and investors, as well as banks, private equity firms and small business investment companies that provide financing to early-stage private companies. He received his J.D. from the Maryland University School of Law in 1990.

Morton is also President of the Maryland Chapter of the Association of Corporate Growth, and teaches an undergraduate entrepreneurial course on technology transfer at Johns Hopkins University.
State-funded TEDCO provides seed funding and technical assistance to emerging tech companies and university researchers, with the goal of helping transfer and commercialize innovations from Maryland-based universities.

Eight Members Named to Mass. Gov. Deval Patrick’s New Council of Economic Advisors

Massachusetts Gov. Deval Patrick has appointed eight members to his Council of Economic Advisors, which held its first meeting March 10. The council will advise Patrick on matters related to economic development in Massachusetts, with an eye to enhancing the state’s economic competitiveness.
  • Cathy Minehan, former president and CEO of the Federal Reserve Bank of Boston, will chair the council, whose other members include: 
  • Gloria Larson, president of Bentley College in Waltham, Mass. 
  • Lisa Lynch, incoming dean of Brandeis University’s Heller School for Social Policy and Management, also in Waltham, and chair of the board of directors of the Boston Federal Reserve Bank. 
  • Jack Meyer, founder of the Boston hedge fund Convexity Capital Management, and the former CEO of Harvard University’s money management entity, Harvard Management Company, who grew the university’s endowment from $4.7 billion to $22.6 billion during his 15-year tenure there. 
  • Henri Termeer, chairman, president and CEO of biotech giant Genzyme, headquartered in Cambridge, Mass. 
  • Stuart Reese, president and CEO of MassMutual Financial Group, headquartered in Springfield, Mass. 
  • James Stock, chairman of the department of economics at Harvard University since 2006.
  • Joe Tucci, chairman, president, and CEO of EMC Corporation, the developer and provider of information infrastructure technology and solutions headquartered in Hopkinton, Mass.

CB Richard Ellis Adds Veteran Broker to Its Northern California Investment Sales Team
Joe Moriarty has joinedthe real estate firmCB Richard Ellis, where he will specialize in investments and corporate advisory services as a member of the firm’s investment sales team focused on selling commercial properties in Northern California.
Moriarty previously worked at Commercial Property Services, where last year he completed $3 billion in transactions that included the leasing of more than 6 million square feet, and the sales of more than 18 million square feet, and 65 acres. The value of the deals was about as much as was completed last year by Moriarty’s new colleagues at CBRE’s Northern California investment sales team, based in San Jose — Bob Gilley, Steve Hermann, and Erik Doyle, all executive vice presidents. Significant assignments for the CBRE team last year included Bay Center Offices, Emeryville, Centennial Towers, South San Francisco and 140 New Montgomery, San Francisco.
While at CPS, based in Santa Clara, Calif., Moriarty received Top Five awards for 2004 and 2005, as well as the company’s President’s Club designation for top brokers from 2002-2007. In 1998 he received two rookie of the year awards from the Association of Silicon Valley Brokers and BT Commercial.
Moriarty received his BSci degree from Southern Methodist University and his MBA from the Wharton School of Business.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.